openPR Logo
Press release

Myotonic Dystrophy Drug Market Size | COVID-19 Impact Analysis | Forecast to 2028

03-23-2022 09:52 AM CET | Health & Medicine

Press release from: Orion Market Research

The global myotonic dystrophy drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Myotonic dystrophy is a muscular dystrophy caused by a long-term genetic mutation. It is the most common type of muscular dystrophy in adulthood, affecting roughly one out of every 8,000 people. Muscle atrophy and weakness worsen over time as a symptom. Muscles contract frequently and take a long time to relax. Some people have a relatively mild type, while others have a severe one that affects them from birth. This is owing to the condition's molecular foundation, which is caused by a dynamic mutation called a triplet repeat expansion, which occurs when three base pairs of DNA are present in varied copies numbers.

To Request a Sample of our Report on Myotonic Dystrophy Drug Market:

The primary factor propelling the growth of global myotonic dystrophy market is the introduction of novel disease therapeutics and increased R&D activities. For instance, in November 2021, Locanabio, Inc., a genetic pharmaceuticals business focused on developing therapies for patients with severe neuromuscular, neurodegenerative, and retinal illnesses, announced new preclinical data from its myotonic dystrophy type 1 (DM1) program. Locanabio scientists used their CORRECTx platform to show a dose-dependent reduction in toxic CUG foci in both DM1 patient muscle cells and a preclinical mouse model of DM1, which resulted in an alternative RNA splicing correction and a statistically significant reduction in myotonia, or muscle weakness. Further, in April 2020, Scientists from the University's Schools of Life Sciences and Chemistry have discovered that inhibiting a molecule in patients' cells called CDK12 can potentially develop a therapy to alleviate some of the symptoms and support treat this incurable condition.

Some major key players in the market include Isis Pharmaceuticals, Inc., and Lupin Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in October 2021, AOC 1001 has been granted Fast Track designation by the Food and Drug Administration (FDA) for the treatment of myotonic dystrophy type 1 (DM1). AOC 1001 is a monoclonal antibody that binds to transferrin receptor 1 and is coupled to a short interfering RNA that targets DMPK mRNA. AOC 1001 is expected to address the fundamental cause of DM1 by lowering DMPK mRNA levels in skeletal, cardiac, and smooth muscle. Data from preclinical tests back up the designation, showing that AOC 1001 successfully transported the small interfering RNA to muscle cells, resulting in dose-dependent decreases in DMPK mRNA.

Market Coverage

· The market number available for - 2021-2028

· Base year- 2021

· Forecast period- 2022-2028

Segment Covered-

· By Type

· By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Isis Pharmaceuticals, Inc., and Lupin Ltd., among others.

(Get 15% Discount on Buying this Report)

A full Report of Myotonic Dystrophy Drug MarketReceiver is Available @

Global Myotonic Dystrophy Drug Market Report by Segment

By Type

· Myotonic Dystrophy Type 1 (DM1)

· Myotonic Dystrophy Type 2 (DM2)

By Application

· Hospital

· Clinic

· Others

Global Myotonic Dystrophy Drug Market Report by Region

North America

· United States

· Canada


· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe


· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Myotonic Dystrophy Drug Market Size | COVID-19 Impact Analysis | Forecast to 2028 here

News-ID: 2584519 • Views:

More Releases from Orion Market Research

Solar Farm Market is Dazzling Worldwide and Forecast to 2031
Solar Farm Market is Dazzling Worldwide and Forecast to 2031
Solar farm market is anticipated to grow at a CAGR of 14.5% during the forecast period (2024-2031). The solar farm market is expected to grow exponentially in the future, attributed to the increasing support by state-run organizations to develop and deploy solar projects in their respective regions. Major fossil fuel-dependent economies and developing regions are focusing on strengthening their solar-based energy production to diversify electricity production sources, reduce fossil fuel dependence,
Regenerative Agriculture Market to Witness Growth Acceleration by 2031/ Nestle S.A., Danone S.A., Cargill, Inc., General Mills, Inc., and Unilever Plc
Regenerative Agriculture Market to Witness Growth Acceleration by 2031/ Nestle S …
The global regenerative agriculture market is anticipated to grow at a considerable CAGR of 14.3% during the forecast period (2024-2031).  The ongoing market developments such as investment in regenerative farming, mergers & acquisitions, and collaboration are anticipated to drive the growth of the global regenerative agricultural market. For instance, in October 2022, through the Nescafé Plan 2030, the company announced to invest over 1 billion Swiss francs (1 Swiss franc = 1.02
Processed Seafood Market Worldwide Industry Analysis, Future Demand and Forecast till 2031 Abad Fisheries Pvt. Ltd., Greenland Seafood Europe GmbH, High Liner Foods Incorporated, Trident Seafoods Corporation
Processed Seafood Market Worldwide Industry Analysis, Future Demand and Forecast …
The global processed seafood market  is anticipated to grow at a significant CAGR of 3.9% during the forecast period. The beneficial properties of processed seafood attract consumers and increase the consumption of seafood. Processed seafood contains vitamin B12, phosphorus, magnesium, potassium, and others, which are also medically recommended and beneficial to keeping low cholesterol levels and fighting cancer and tumour growth. The benefits associated with the consumption of processed seafood such as
Processed Mango Products Market is Likely to Increase at a Significantly High CAGR during Forecast Period 2031 | Capricorn Food Products India Ltd., FPD Food International, Inc., Sunrise Naturals Pvt.Ltd., Ambrosia Organic Farm, MOTHER INDIA FARMS.
Processed Mango Products Market is Likely to Increase at a Significantly High CA …
Processed Mango Products Market is anticipated to grow at a significant CAGR of 6.3% during the forecast period. Mangoes are processed into food products such as chutney, pickles, curries, dehydrated products, puree, canned and frozen slices, juices, and other products. People are highly consuming mango and processed mango products which is expected to boost the growth of processed mango products market. In addition, the increasing health consiouseness among consumers and

All 5 Releases

More Releases for Myotonic

Myotonic Muscular Dystrophy Market Size will Observe Substantial Growth by 2027| …
A Muscular dystrophy refers to a group of nine genetic diseases that cause progressive weakness and degeneration of muscles used during voluntary movement. Myotonic dystrophy is one of the muscular dystrophies. It is the most common form seen in adults and is suspected to be among the most common forms overall. Myotonic muscular dystrophy is a common multi-system disorder that affects the skeletal muscles as well as smooth muscles and
Myotonic Dystrophy Drug Market Indeep Research And Detailed Analysis- Lupin, Tev …
MarketInsightsReports, a leading global market research firm, is pleased to announce its new report on Myotonic Dystrophy Drug market, forecast for 2021-2027, covering all aspects of the market and providing up-to-date data on current trends. The Myotonic Dystrophy Drug Market report provides the overall structure and business outlook of the global and regional industries. The study also involves the important Achievements of the market, Research & Development, new product launch, product
Global Myotonic Dystrophy Therapeutics Market Report Forecast to 2027
The report entitled Myotonic Dystrophy Therapeutics Market (2021-2027) Size, Trends and Forecast provides an in-depth analysis of the Myotonic Dystrophy Therapeutics Market including detailed description of market sizing and growth, value, the key opportunities in the Myotonic Dystrophy Therapeutics Market and outlines the factors that are and will be driving the growth of the industry taking into consideration the previous growth patterns. Get sample copy of this report @
Myotonic Dystrophy Drug Market Report Delivering Growth Analysis With Key Trends …
Up Market Research (UMR) offers a detailed report on Global Myotonic Dystrophy Drug Market. The report is a comprehensive research study that provides the scope of Myotonic Dystrophy Drug market size, industry growth opportunities and challenges, current market trends, potential players, and expected performance of the market in regions for the forecast period from 2020 to 2027. This report highlights key insights on the market focusing on the possible requirements
Myotonic Muscular Dystrophy Market: Industry Size, Share, Growth, Forecasts 2017 …
"Myotonic Muscular Dystrophy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025 " is the latest addition to MarketResearchReports.Biz industry research reports collection. The objectives of this study are as follows: To define, describe, and forecast the "Myotonic Muscular Dystrophy" market by type, application, component, delivery model, end user, and region To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges) To analyze
Global Myotonic Dystrophy Drug Sales Market Report 2018
YT Research Group recently published a report on “Global Myotonic Dystrophy Drug Sales Market Report 2018”. In this report, the global Myotonic Dystrophy Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million